ArticlePediatric pulmonology2020

Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations.

Jacelyn E Peabody Lever et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.